United States
Germany
Japan
United Kingdom
China
Antibodies
Recombinant Anti-TRP-1, gp75 (Clone TA99)
| Applications | ELISA, FC, IF, IHC, IP, WB |
| Reactivities | Human |
Recombinant Anti-CD80 (Clone IDEC-114 (Galiximab))
| Applications | Bl, ELISA, FC, IHC, IP, WB |
| Reactivities | Human |
Peptidase 1 / DERP1 human monoclonal antibody, clone H.AA.IV7A3
| Applications | ELISA, WB |
| Reactivities | Human |
DERP2 human monoclonal antibody, clone H.AK6.A3.F4
| Applications | ELISA, WB |
| Reactivities | Human |
Recombinant Anti-VEGF (Clone Bevacizumab)
| Applications | Bl, ELISA, FC, IP, WB |
| Reactivities | Human |
Peptidase 1 / DERP1 human monoclonal antibody, clone H.AK5.C
| Applications | ELISA, WB |
| Reactivities | Human |
Recombinant Anti-Human Ephrin Type A receptor 2 (Clone 1C1)
| Applications | ELISA, FC, IF, WB |
| Reactivities | Human |
Anti-Modified cytokeratin [COU-1], Human IgM, kappa
| Applications | ELISA, ICC, IHC, WB |
| Reactivities | Human |
Anti-Laminin-2 LG5 [C3_Hu10], Human IgG1, kappa
| Applications | ELISA, FC, IF, WB |
| Reactivities | Human, Mouse |
Recombinant Anti-EGFR (Clone 2F8 (Zalutumumab; HuMax-EGFR))
| Applications | ELISA, FC, WB |
| Reactivities | Human |
Recombinant Anti-ED-B domain of fibronectin (Clone A2)
| Applications | ELISA, IHC, WB |
| Reactivities | Human |
Recombinant Anti-ED-B domain of fibronectin (Clone G4)
| Applications | ELISA, IHC, WB |
| Reactivities | Human |
